These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27233261)

  • 41. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
    Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
    Viruses; 2019 May; 11(5):. PubMed ID: 31052472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of in-house serological methods for diagnosis and surveillance of chikungunya.
    Galo SS; González K; Téllez Y; García N; Pérez L; Gresh L; Harris E; Balmaseda Á
    Rev Panam Salud Publica; 2017 Aug; 41():e56. PubMed ID: 28902269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection.
    Erasmus JH; Needham J; Raychaudhuri S; Diamond MS; Beasley DW; Morkowski S; Salje H; Fernandez Salas I; Kim DY; Frolov I; Nasar F; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(10):e0004119. PubMed ID: 26492074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of chikungunya virus-specific IgM on laser-cut paper-based device using pseudo-particles as capture antigen.
    Theillet G; Grard G; Galla M; Maisse C; Enguehard M; Cresson M; Dalbon P; Leparc-Goffart IL; Bedin F
    J Med Virol; 2019 Jun; 91(6):899-910. PubMed ID: 30734316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
    Kam YW; Lee WW; Simarmata D; Le Grand R; Tolou H; Merits A; Roques P; Ng LF
    PLoS One; 2014; 9(4):e95647. PubMed ID: 24755730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzootic Circulation of Chikungunya Virus in East Africa: Serological Evidence in Non-human Kenyan Primates.
    Eastwood G; Sang RC; Guerbois M; Taracha ELN; Weaver SC
    Am J Trop Med Hyg; 2017 Nov; 97(5):1399-1404. PubMed ID: 29016323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
    Goo L; Dowd KA; Lin TY; Mascola JR; Graham BS; Ledgerwood JE; Pierson TC
    J Infect Dis; 2016 Nov; 214(10):1487-1491. PubMed ID: 27655868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High seroprevalence of chikungunya virus antibodies among pregnant women living in an urban area in Benin, West Africa.
    Bacci A; Marchi S; Fievet N; Massougbodji A; Perrin RX; Chippaux JP; Sambri V; Landini MP; Varani S; Rossini G
    Am J Trop Med Hyg; 2015 Jun; 92(6):1133-6. PubMed ID: 25940198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of recombinant E2 protein based IgM capture enzyme-linked immunosorbent assay (ELISA) and double antigen sandwich ELISA for detection of antibodies to Chikungunya virus.
    Guo M; Du S; Lai L; Wu W; Huang X; Li A; Li H; Li C; Wang Q; Sun L; Liu T; Tian T; Wang S; Liang M; Li D; Xie C; Li J
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010829. PubMed ID: 36480572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model.
    Goh LY; Hobson-Peters J; Prow NA; Gardner J; Bielefeldt-Ohmann H; Pyke AT; Suhrbier A; Hall RA
    Clin Immunol; 2013 Dec; 149(3):487-97. PubMed ID: 24239837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
    Prince HE; Seaton BL; Matud JL; Batterman HJ
    Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological evidence of widespread exposure of Grenada fruit bats to chikungunya virus.
    Stone D; Lyons AC; Huang YS; Vanlandingham DL; Higgs S; Blitvich BJ; Adesiyun AA; Santana SE; Leiser-Miller L; Cheetham S
    Zoonoses Public Health; 2018 Aug; 65(5):505-511. PubMed ID: 29575672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results.
    Kizu J; Graham M; Liu W
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
    Lum FM; Couderc T; Chia BS; Ong RY; Her Z; Chow A; Leo YS; Kam YW; Rénia L; Lecuit M; Ng LFP
    Sci Rep; 2018 Jan; 8(1):1860. PubMed ID: 29382880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
    Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
    Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
    Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
    Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and Validation of a Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in the Americas.
    Reddy A; Bosch I; Salcedo N; Herrera BB; de Puig H; Narváez CF; Caicedo-Borrero DM; Lorenzana I; Parham L; García K; Mercado M; Turca AMR; Villar-Centeno LA; Gélvez-Ramírez M; Ríos NAG; Hiley M; García D; Diamond MS; Gehrke L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32882998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutralization activity of patient sera collected during the 2008-2009 Chikungunya outbreak in Thailand.
    Kishishita N; Sasayama M; Takeda N; Sa-Ngasang A; Anuegoonpipat A; Anantapreecha S
    J Clin Microbiol; 2015 Jan; 53(1):184-90. PubMed ID: 25378567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.